Skip to main content
Log in

The advance of bacterididal drugs in the treatment of infection

  • Invited Commentary
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Levison ME: Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects. Infect Dis Clin North Am 1995, 9:483–495.

    PubMed  CAS  Google Scholar 

  2. Hooper DC: Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001, 32(Suppl 1):S9-S15.

    Article  PubMed  CAS  Google Scholar 

  3. Tally FP, DeBruin MF: Development of daptomycin for grampositive infections. J Antimicrob Chemother 2000, 46:523–526.

    Article  PubMed  CAS  Google Scholar 

  4. Diekema DJ, Jones RN: Oxazolidinone antibiotics. Lancet 2001, 358:1975–1982.

    Article  PubMed  CAS  Google Scholar 

  5. Brisson-Noel A, Trieu-Cuot P, Courvalin P: Mechanism of action of spiramycin and other macrolides. J Antimicrob Chemother 1988, 22(Suppl B):13–23.

    PubMed  CAS  Google Scholar 

  6. Smilack JD: The tetracyclines. Mayo Clin Proc 1999, 74:727–729.

    PubMed  CAS  Google Scholar 

  7. Quinlivan EP, McPartlin J, Weir DG, Scott J: Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J 2000, 14:2519–2524.

    Article  PubMed  CAS  Google Scholar 

  8. Fuchs P, Barry A, Brown S: In vitro bactericidal activity of daptomycin against staphylococci. J Antimicrob Chemother 2002, 49:467–470.

    Article  PubMed  CAS  Google Scholar 

  9. Gradelski E, Valera L, Kolek B, et al.: Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams. Int J Antimicrob Agents 2001, 18:43–48.

    Article  PubMed  CAS  Google Scholar 

  10. Firsov A, Vostrov S, Lubenko I, et al.: In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:1604–1613.

    Article  PubMed  CAS  Google Scholar 

  11. Bozgogan B, Esel D, Whitener C, et al.: Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 2003, 52:864–868.

    Article  CAS  Google Scholar 

  12. Mylonakis E, Calderwood SB: Infective endocarditis in adults. N Engl J Med 2001, 345:1318–1330.

    Article  PubMed  CAS  Google Scholar 

  13. Jacobs RF: Cefotaxime treatment of gram-negative enteric meningitis in infants and children. Drugs 1988, 35(Suppl 2):185–189.

    Article  PubMed  Google Scholar 

  14. McCracken GH Jr, Mize SG: A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr 1976, 89:66–72.

    Article  PubMed  Google Scholar 

  15. Lepper MH, Dowling HF: Treatment of pneumococcal meningitis with penicillin compared with penicillin plus aureomycin. Arch Intern Med 1951, 88:489.

    CAS  Google Scholar 

  16. Schimpff S, Satterlee W, Young VM, Serpick A: Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971, 284:1061–1065.

    Article  PubMed  CAS  Google Scholar 

  17. Bodey GP: Synergy. Should it determine antibiotic selection in neutropenic patients? Arch Intern Med 1985, 145:1964–1966.

    Article  PubMed  CAS  Google Scholar 

  18. Mattoes H, Banevicius M, Li D, et al.: Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae. Antimicrob Agents Chemother 2001, 45:2092–2097.

    Article  PubMed  CAS  Google Scholar 

  19. Dagan R, Klugman K, Craig W, et al.: Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001, 47:129–140.

    Article  PubMed  CAS  Google Scholar 

  20. Boccazzi A, Tonelli P, DeAngelis M, et al.: Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. Pediatr Infect Dis J 2000, 19:963–967.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alder, J., Eisenstein, B. The advance of bacterididal drugs in the treatment of infection. Curr Infect Dis Rep 6, 251–253 (2004). https://doi.org/10.1007/s11908-004-0042-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-004-0042-1

Keywords

Navigation